The arena of therapeutics for Niemann-Pick Disease Type C (NPC) is a dynamic one, with notable strides being made in investigation. Several promising therapeutic methods are currently undergoing clinical trials, offering hope for sufferers living with this uncommon and worsening brain-related disorder. A combination of drug-driven therapies and mo… Read More